303 related articles for article (PubMed ID: 29633562)
1. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
Lazarus JV; Stumo SR; Harris M; Hendrickx G; Hetherington KL; Maticic M; Jauffret-Roustide M; Tallada J; Simojoki K; Reic T; Safreed-Harmon K;
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25052. PubMed ID: 29633562
[TBL] [Abstract][Full Text] [Related]
2. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
3. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
[TBL] [Abstract][Full Text] [Related]
4. State of viral hepatitis care in 16 countries of Central and Eastern European Region.
Chkhartishvili N; Holban T; Simonović Babić J; Alexiev I; Matičič M; Kowalska J; Horban A;
Cent Eur J Public Health; 2019 Sep; 27(3):212-216. PubMed ID: 31580556
[TBL] [Abstract][Full Text] [Related]
5. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.
Duffell EF; Hedrich D; Mardh O; Mozalevskis A
Euro Surveill; 2017 Mar; 22(9):. PubMed ID: 28277217
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.
Wait S; Kell E; Hamid S; Muljono DH; Sollano J; Mohamed R; Shah S; Mamun-Al-Mahtab ; Abbas Z; Johnston J; Tanwandee T; Wallace J
Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):248-255. PubMed ID: 28404097
[TBL] [Abstract][Full Text] [Related]
7. Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries.
Maticic M; Zorman JV; Gregorcic S; Schatz E; Lazarus JV
Harm Reduct J; 2019 May; 16(1):32. PubMed ID: 31072401
[TBL] [Abstract][Full Text] [Related]
8. The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries.
Maticic M; Pirnat Z; Leicht A; Zimmermann R; Windelinck T; Jauffret-Roustide M; Duffell E; Tammi T; Schatz E
Harm Reduct J; 2020 Nov; 17(1):89. PubMed ID: 33213481
[TBL] [Abstract][Full Text] [Related]
9. Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study.
Safreed-Harmon K; Hetherington KL; Aleman S; Alho H; Dalgard O; Frisch T; Gottfredsson M; Weis N; Lazarus JV;
PLoS One; 2018; 13(1):e0190146. PubMed ID: 29381697
[TBL] [Abstract][Full Text] [Related]
10. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
Hatzakis A; Wait S; Bruix J; Buti M; Carballo M; Cavaleri M; Colombo M; Delarocque-Astagneau E; Dusheiko G; Esmat G; Esteban R; Goldberg D; Gore C; Lok AS; Manns M; Marcellin P; Papatheodoridis G; Peterle A; Prati D; Piorkowsky N; Rizzetto M; Roudot-Thoraval F; Soriano V; Thomas HC; Thursz M; Valla D; van Damme P; Veldhuijzen IK; Wedemeyer H; Wiessing L; Zanetti AR; Janssen HL
J Viral Hepat; 2011 Sep; 18 Suppl 1():1-16. PubMed ID: 21824223
[TBL] [Abstract][Full Text] [Related]
11. Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey.
Spina A; Eramova I; Lazarus JV
BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S15. PubMed ID: 25252705
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological characteristics and access to end-stage liver disease care for HIV-positive patients with HCV and/or HBV coinfections in Central/Eastern European and neighboring countries – data from the ECEE network.
Skrzat-Klapaczyńska A; Matłosz B; Otelea D; Harxhi A; Vassilenko A; Bolokadze N; Rüütel K; Papadopoulos A; Mardarescu M; Youle M; Kowalska JD; Horban A
Przegl Epidemiol; 2019; 73(1):61-68. PubMed ID: 31134775
[TBL] [Abstract][Full Text] [Related]
13. Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017.
Smith S; Harmanci H; Hutin Y; Hess S; Bulterys M; Peck R; Rewari B; Mozalevskis A; Shibeshi M; Mumba M; Le LV; Ishikawa N; Nolna D; Sereno L; Gore C; Goldberg DJ; Hutchinson S
JHEP Rep; 2019 Aug; 1(2):81-89. PubMed ID: 32039355
[TBL] [Abstract][Full Text] [Related]
14. Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
Palayew A; Razavi H; Hutchinson SJ; Cooke GS; Lazarus JV
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):948-953. PubMed ID: 32730784
[TBL] [Abstract][Full Text] [Related]
15. Securing sustainable funding for viral hepatitis elimination plans.
Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
[TBL] [Abstract][Full Text] [Related]
16. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
Abruzzi A; Fried B; Alikhan SB
Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
[TBL] [Abstract][Full Text] [Related]
19. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.
Ishizaki A; Bouscaillou J; Luhmann N; Liu S; Chua R; Walsh N; Hess S; Ivanova E; Roberts T; Easterbrook P
BMC Infect Dis; 2017 Nov; 17(Suppl 1):696. PubMed ID: 29143609
[TBL] [Abstract][Full Text] [Related]
20. Barriers and Strategies for Hepatitis B and C Elimination in Pakistan.
Qureshi H; Mahmood H; Sabry A; Hermez J
J Infect Dis; 2023 Sep; 228(Suppl 3):S204-S210. PubMed ID: 37703344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
